| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/27/2008 | EP1961760A2 Peptides and compounds that bind to a thrombopoietin receptor |
| 08/27/2008 | EP1961759A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 08/27/2008 | EP1961428A1 SC6 antibody for treatment of cancer |
| 08/27/2008 | EP1961425A2 Methods and compositions for the prevention and treatment of anemia |
| 08/27/2008 | EP1961424A1 Activation of peptide prodrugs by HK2 |
| 08/27/2008 | EP1961414A1 A controlled release composition comprising a recombinant gelatin |
| 08/27/2008 | EP1961065A2 Compositions and methods for diagnosing and treating cancer |
| 08/27/2008 | EP1960523A1 Modified pore-forming protein toxins and use thereof |
| 08/27/2008 | EP1960515A1 Anti-inflammatory peptides |
| 08/27/2008 | EP1960426A1 Novel neurotrophic factor protein and uses thereof |
| 08/27/2008 | EP1960422A2 Potent compstatin analogs |
| 08/27/2008 | EP1960420A2 Novel compounds which interact with pea-15 |
| 08/27/2008 | EP1959999A2 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same |
| 08/27/2008 | EP1959994A2 Botulinum nanoemulsions |
| 08/27/2008 | EP1959988A1 Use of transferrins for treating destructive inflammation of mucous membrane |
| 08/27/2008 | EP1959987A2 Mucosal delivery of stabilized formulations of exendin |
| 08/27/2008 | EP1959986A2 Glucagon analogs exhibiting physiological solubility and stability |
| 08/27/2008 | EP1959985A2 Use of prolactin in the prophylactic treatment of cancer |
| 08/27/2008 | EP1959984A2 Methods of treating cartilage defects |
| 08/27/2008 | EP1959983A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 08/27/2008 | EP1959982A1 Methods and compositions for preventing and/or treating pancreatitis |
| 08/27/2008 | EP1959981A2 Anti-connexin compounds and therapeutic uses thereof |
| 08/27/2008 | EP1959980A2 Treatment of neurodegenerative disorders |
| 08/27/2008 | EP1959979A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons |
| 08/27/2008 | EP1959978A1 Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer |
| 08/27/2008 | EP1959968A2 Modulation of the p2y2 receptor pathway |
| 08/27/2008 | EP1959950A1 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 08/27/2008 | EP1959760A1 High-potency sweetener for weight management and compositions sweetened therewith |
| 08/27/2008 | EP1959755A1 High-potency sweetener composition with c-reactive protein reducing substance and compositions sweetened therewith |
| 08/27/2008 | EP1709066B1 Inclusion complexes of perindopril |
| 08/27/2008 | EP1603584B1 Aplidine for multiple myeloma treatment |
| 08/27/2008 | EP1440156B1 Antigens and vectors for vaccination |
| 08/27/2008 | EP1355942B1 Glp-1 fusion proteins |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1272212B1 Migraine and vasodilation treatment |
| 08/27/2008 | EP1257564B1 Process for purification of recombinant hcg having a specific bioactivity |
| 08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
| 08/27/2008 | EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/27/2008 | EP1156817B1 Controlling protein levels in eucaryotic organisms |
| 08/27/2008 | EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B |
| 08/27/2008 | EP1090026B1 Diacylglycerol o-acyltransferase |
| 08/27/2008 | EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1 |
| 08/27/2008 | EP1007555B1 Tropoelastin derivatives |
| 08/27/2008 | EP0949931B1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 08/27/2008 | CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 08/27/2008 | CN101252949A Promotion of epithelial regeneration |
| 08/27/2008 | CN101252948A Method of repairing meniscus tears |
| 08/27/2008 | CN101252947A Nutrient composition |
| 08/27/2008 | CN101252946A Methods for the rapid expansion of antigen specific T-cells |
| 08/27/2008 | CN101250547A Recombinant expression of human desmocyte growth factor-21 |
| 08/27/2008 | CN101250531A Nucleotide sequence, expression vector containing the same, zooblast inverted from said vector and method for producing human fsh using the zooblast |
| 08/27/2008 | CN101250510A Method for constructing hepatitis C virus specific ribozyme M1GS-hcv/C20 and uses thereof |
| 08/27/2008 | CN101250222A Ascidian antibacterial peptide, precursor peptide, coding gene and use thereof |
| 08/27/2008 | CN101250219A Short peptide series suppressing growth of leukemia cancer cell and uses thereof |
| 08/27/2008 | CN101249278A Bone induction material and preparation method and application thereof |
| 08/27/2008 | CN101249262A Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 08/27/2008 | CN101249259A High content and high activity oral polysaccharide-peptide and preparing method and application of the same |
| 08/27/2008 | CN101249258A An uro-genital condition treatment system |
| 08/27/2008 | CN101249077A Preparation of degradable pollutant polyalcohol stephanoporate microballoons and uses thereof |
| 08/27/2008 | CN101249061A Hoarfrost for detoxifcation and anti-inflammation and method of preparing the same |
| 08/27/2008 | CN101248998A Vacuum hemostix |
| 08/27/2008 | CN100413970C Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor S2 immune decision cluster |
| 08/27/2008 | CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/27/2008 | CN100413888C Soluble polypeptides |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413884C Process for extracting protein/polypeptide-K from i(momordica charantia), products and use thereof |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413878C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/27/2008 | CN100413538C Remedy for corneal failure |
| 08/27/2008 | CN100413535C Application of nerve growth factor in preparation of medicine for effective reducing body weight |
| 08/27/2008 | CN100413534C Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method |
| 08/27/2008 | CN100413533C Sustained release pharmaceutical compounds to prevent abuse of controlled substances |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/26/2008 | US7417135 Expression vector comprising nucleotide sequences coding lytic enzyme for use as gene transfer tool in generating transgenic lactobacillus with enhanced amylase activity; improving digestibility of animal feeds |
| 08/26/2008 | US7417134 IL-1 receptor based cytokine traps and method of using |
| 08/26/2008 | US7417133 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
| 08/26/2008 | US7417130 DNA library comprising nucleotide sequences coding polypeptide containing leucine repeats for monitoring binding and regulation of ligand and cofactor interactions |
| 08/26/2008 | US7417128 7C10 and 16C10 CD80-specific antibodies |
| 08/26/2008 | US7417125 Chimeric humanized monoclonal antibody for treating tumors and inflammation |
| 08/26/2008 | US7417124 Polyclonal antibody specific for phosphorylated linker region in preferential transcription factor (SMAD) for use as tool in preventionand treatment of hepatic fibrosis and cell proliferative disorders; tissue targeted therapy; antitumor agents |
| 08/26/2008 | US7417123 PRO4399 Antibodies |
| 08/26/2008 | US7417122 Mammalian galanin receptors |
| 08/26/2008 | US7417121 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 08/26/2008 | US7417118 Pharmaceutical composition containing artificial oxygen carrier |
| 08/26/2008 | US7417115 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417042 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
| 08/26/2008 | US7417035 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 08/26/2008 | US7417030 Thrombolytic agents, restenosis, hypotension agents, heart failure, antiarrhythmia and -inflammation agents, angina, stroke, atherosclerosis, antiischemic agents, angiogenesis related disorders, anti carcinogenic and -tumor agents |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7417028 Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions |
| 08/26/2008 | US7417027 For decreasing food intake; eating disorders; sexual disorders |
| 08/26/2008 | US7417026 Mobilization of hematopoietic cells |
| 08/26/2008 | US7417025 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
| 08/26/2008 | US7417024 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |
| 08/26/2008 | US7417023 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |